Podcasts

Only half of people with multidrug resistant TB are cured, and patients run a high risk of losing their hearing due to the drugs.

Towards the end of the year, donated batches of the anti-HIV jab, CAB-LA, will arrive in South Africa. The two-monthly jab will be used in implementation trials and virtually wipes out someone’s chances of contracting HIV through sex. How much will donors and the South African health department have to pay for such injections and can the drugmaker, ViiV Healthcare, make enough of them? In this podcast, Mia Malan asks Mitchell Warren, who leads a group of organisations and donors who look at ways to make the jab available as fast as possible, for answers.

TB is not only found in the lungs. You can get TB anywhere in your body, but it is very difficult to diagnose.

Here’s how paramedics are fighting for their own lives so they can save yours.

Where did the Zika virus come from, and just how closely linked to microcephaly is it? SA's National Institute for Communicable Diseases explains all.

In 2016, Bhekisisa started to do solutions journalism. But what is it? "Think Sherlock Holmes or Agatha Christie," David Bornstein from the Solutions Journalism Network tells Bhekisisa's editor Mia Malan. "These are stories that answer 'the how.'" 

If you're a young woman, would you take a two-in-one HIV prevention pill? Mia Malan and Kevin Rebe talk PrEP and contraception.

The promotion of e-cigarettes has led to a rise in vaping. Bhekisisa’s three-part narrative podcast looks at how vaping has evolved in South Africa and finds out if it’s a useful innovation in a world where regular cigarettes are becoming unacceptable. Or is it simply another method of delivering nicotine to a lucrative new and younger market?

As the hearings continue this week, Laura Lopez Gonzalez speaks to Nelisiwe Msomi about the arbitration process.

We take you into the world of brothels and show you how a clinic gets HIV prevention pills and antiretroviral drugs to sex workers in an environment where they don't have to fear being arrested.

A month into the foreign aid crisis that the Trump administration’s funding cuts have resulted in, the big question in the HIV world is: what will happen to the US government’s Aids fund, Pepfar? In this podcast, Mia Malan asks former Pepfar head of staff, Jirair Ratevosian, what the future holds, and what will happen if the US government stops its contributions to the Global Fund for HIV, TB and Malaria.

South Africa's second monkeypox case was confirmed on Tuesday — a 32-year old man from Cape Town. The first case was confirmed on June 22 and was a male, 30, from Johannesburg. Neither of them have a travel history.

As children, they escaped the virus through revolutions in medication. But today, they face an old foe again. Renowned HIV scientist Salim Abdool Karim sits down with Mia Malan to explain why their story is the story of Africa’s HIV epidemic.

HIV doctor Francois Venter explains why the treatment of obese people reminds him of the bad old days of the HIV epidemic.

In the late 2000s, a trio of businessmen smuggled expired ARVs from Africa into Europe and sold them at a 4 000% markup. This is why it's news now.

Truvada is available in SA's private health sector and is in the process of being expanded to the public sector. Mia Malan talks PrEP with Kevin Rebe.